An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
type: MedicalStudy
description: An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE1,PHASE2
start date: 2007-08
end date: 2010-09
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00561197
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Ascenta Therapeutics
study subject: Locally Advanced Esophageal or GE Junction Cancer
keywords: PHASE1,PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Locally Advanced Esophageal or GE Junction Cancer

AI Analytics
type: Organization